OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vesical Imaging‐Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer
Andrea Necchi, Giuseppe Basile, Ewan A. Gibb, et al.
BJU International (2023) Vol. 133, Iss. 2, pp. 214-222
Open Access | Times Cited: 13
Andrea Necchi, Giuseppe Basile, Ewan A. Gibb, et al.
BJU International (2023) Vol. 133, Iss. 2, pp. 214-222
Open Access | Times Cited: 13
Showing 13 citing articles:
The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee
Valeria Panebianco, Alberto Briganti, Jason A. Efstathiou, et al.
European Urology (2024) Vol. 86, Iss. 6, pp. 485-487
Closed Access | Times Cited: 4
Valeria Panebianco, Alberto Briganti, Jason A. Efstathiou, et al.
European Urology (2024) Vol. 86, Iss. 6, pp. 485-487
Closed Access | Times Cited: 4
Multiparametric MRI for Bladder Cancer: A Practical Approach to the Clinical Application of VI-RADS
Martina Pecoraro, Stefano Cipollari, Emanuele Messina, et al.
Radiology (2025) Vol. 314, Iss. 3
Closed Access
Martina Pecoraro, Stefano Cipollari, Emanuele Messina, et al.
Radiology (2025) Vol. 314, Iss. 3
Closed Access
Aplicaciones clínicas de la resonancia magnética de vejiga: más allá de la clasificación VIRADS®
J. Etxano, A. López-Maseda
Radiología (2025)
Closed Access
J. Etxano, A. López-Maseda
Radiología (2025)
Closed Access
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G. van der Heijden, Harman Max Bruins, Albert Carrión, et al.
European Urology (2025)
Closed Access
Antoine G. van der Heijden, Harman Max Bruins, Albert Carrión, et al.
European Urology (2025)
Closed Access
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance
Benjamin I. Joffe, John R. Christin, Clémentine Le Coz, et al.
Current Urology Reports (2025) Vol. 26, Iss. 1
Closed Access
Benjamin I. Joffe, John R. Christin, Clémentine Le Coz, et al.
Current Urology Reports (2025) Vol. 26, Iss. 1
Closed Access
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
Chiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 35, pp. 4196-4205
Closed Access | Times Cited: 3
Chiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 35, pp. 4196-4205
Closed Access | Times Cited: 3
The role of MRI in muscle-invasive bladder cancer: an update from the last two years
Giovanni Luigi Pastorino, Chiara Mercinelli, Andrea Necchi
Current Opinion in Urology (2024)
Closed Access | Times Cited: 1
Giovanni Luigi Pastorino, Chiara Mercinelli, Andrea Necchi
Current Opinion in Urology (2024)
Closed Access | Times Cited: 1
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Giorgio Brembilla, Giuseppe Basile, Michele Cosenza, et al.
Radiology (2024) Vol. 313, Iss. 3
Closed Access | Times Cited: 1
Giorgio Brembilla, Giuseppe Basile, Michele Cosenza, et al.
Radiology (2024) Vol. 313, Iss. 3
Closed Access | Times Cited: 1
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Marco Moschini, Andrea Necchi, Francesco Montorsi
European Urology (2024) Vol. 85, Iss. 5, pp. 500-501
Closed Access
Marco Moschini, Andrea Necchi, Francesco Montorsi
European Urology (2024) Vol. 85, Iss. 5, pp. 500-501
Closed Access
Urologic Imaging of the Bladder
Haleh Amirian, Felipe Franco, Borna E. Dabiri, et al.
Urologic Clinics of North America (2024) Vol. 52, Iss. 1, pp. 111-124
Closed Access
Haleh Amirian, Felipe Franco, Borna E. Dabiri, et al.
Urologic Clinics of North America (2024) Vol. 52, Iss. 1, pp. 111-124
Closed Access
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Daniel M. Geynisman, Philip H. Abbosh, Eric A. Ross, et al.
Journal of Clinical Oncology (2024)
Closed Access
Daniel M. Geynisman, Philip H. Abbosh, Eric A. Ross, et al.
Journal of Clinical Oncology (2024)
Closed Access
Precise vesical wall staging of bladder cancer in the era of precision medicine: has it been fulfilled?
Mohamed Ragab Nouh, Omnia Ezz Eldin
Abdominal Radiology (2024)
Closed Access
Mohamed Ragab Nouh, Omnia Ezz Eldin
Abdominal Radiology (2024)
Closed Access
Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: a prospective validation study
Ailin Dehghanpour, Martina Pecoraro, Emanuele Messina, et al.
European Radiology (2024)
Closed Access
Ailin Dehghanpour, Martina Pecoraro, Emanuele Messina, et al.
European Radiology (2024)
Closed Access
